Guidance for clinicians and patients with non-small cell lung cancer in the time of precision medicine

Major advances in the diagnosis and treatment of non-small cell lung cancer (NSCLC) have resulted in a sharp decline in associated mortality rates, thereby propelling NSCLC to the forefront of precision medicine. Current guidelines recommend upfront comprehensive molecular testing for all known and...

Descripción completa

Detalles Bibliográficos
Autores principales: Villaruz, Liza C., Socinski, Mark A., Weiss, Jared
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107372/
https://www.ncbi.nlm.nih.gov/pubmed/37077826
http://dx.doi.org/10.3389/fonc.2023.1124167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107372/
https://www.ncbi.nlm.nih.gov/pubmed/37077826
http://dx.doi.org/10.3389/fonc.2023.1124167

Ejemplares similares